Bharat Immunologicals & Biologicals (BOM:524663) 5-Year Yield-on-Cost %: 0.00 (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524663 Bharat Immunologicals & Biologicals Corp Ltd BOM:524663
4 GF Score
Price ₹14.16
View Full Analysis

What is Bharat Immunologicals & Biologicals 5-Year Yield-on-Cost %?

Bharat Immunologicals & Biologicals BOM:524663 -2.95% 4 5-Year Yield-on-Cost % is 0.00 as of Sep. 20, 2026. GuruFocus rates BOM:524663 with a GF Score™ of 4/100.

Bharat Immunologicals & Biologicals's yield on cost for the quarter that ended in Sep. 2023 was 0.00.


The historical rank and industry rank for Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost % or its related term are showing as below:



BOM:524663's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.63
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Bharat Immunologicals & Biologicals  (BOM:524663) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Bharat Immunologicals & Biologicals 5-Year Yield-on-Cost % Related Terms

BOM:524663 vs VRTX, REGN, SGEN: 5-Year Yield-on-Cost % Comparison

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bharat Immunologicals & Biologicals 5-Year Yield-on-Cost % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost % falls into.


BOM:524663
4GF Score
Bharat Immunologicals & Biologicals Corp Ltd BOM:524663
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bharat Immunologicals & Biologicals 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Bharat Immunologicals & Biologicals is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Bharat Immunologicals & Biologicals (BOM:524663) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 20, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Bharat Immunologicals & Biologicals and its competitors.
Is Bharat Immunologicals & Biologicals' 5-Year Yield-on-Cost % too high?
Bharat Immunologicals & Biologicals' current 5-Year Yield-on-Cost % is 0.00. Overall, Bharat Immunologicals & Biologicals has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Bharat Immunologicals & Biologicals' 5-Year Yield-on-Cost % compare to VRTX and REGN?
Bharat Immunologicals & Biologicals' 5-Year Yield-on-Cost % of 0.00 can be compared against companies in the Biotechnology industry. The industry median 5-Year Yield-on-Cost % is 1.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.63, based on 148 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Bharat Immunologicals & Biologicals and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bharat Immunologicals & Biologicals's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bharat Immunologicals & Biologicals stock overvalued right now?
Bharat Immunologicals & Biologicals (BOM:524663) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Bharat Immunologicals & Biologicals' overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Bharat Immunologicals & Biologicals (BOM:524663), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bharat Immunologicals & Biologicals Business Description

Address Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.
4GF Score

Get the complete analysis for BOM:524663

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹14.16
Price